Skip to content

Clinical trials

Completed Phase 2/3 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 2/3 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20071
20092
20101
20122
20141
20151
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AgeneBio1
Anne Comi, MD1
Avid Radiopharmaceuticals1
Charite University, Berlin, Germany1
London Health Sciences Centre1
Mandos LLC1
New York State Psychiatric Institute1
Oregon Health and Science University1
Universidad Autonoma de Nuevo Leon1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction14
Alzheimer Disease3
Multiple Sclerosis2
AIDS Dementia Complex1
Alcoholism1
Brain Diseases1
Cognition Disorders1
Deglutition Disorders1
Dementia1
Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.